ArticleThe AAPS journal2023

Model-Informed Approach Supporting Approval of Nexviazyme (Avalglucosidase Alfa-ngpt) in Pediatric Patients with Late-Onset Pompe Disease.

Ruo-Jing Li et al.PubMed ↗Publisher ↗

No numbers read from the abstract.